Deirdra R. Terrell

8.9k total citations · 1 hit paper
100 papers, 5.2k citations indexed

About

Deirdra R. Terrell is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Deirdra R. Terrell has authored 100 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 59 papers in Immunology and 29 papers in Genetics. Recurrent topics in Deirdra R. Terrell's work include Complement system in diseases (58 papers), Blood groups and transfusion (35 papers) and Platelet Disorders and Treatments (32 papers). Deirdra R. Terrell is often cited by papers focused on Complement system in diseases (58 papers), Blood groups and transfusion (35 papers) and Platelet Disorders and Treatments (32 papers). Deirdra R. Terrell collaborates with scholars based in United States, Switzerland and Canada. Deirdra R. Terrell's co-authors include Sara K. Vesely, James N. George, Johanna A. Kremer Hovinga, Bernhard Lämmle, Jessica Reese, Kiarash Kojouri, Laura A. Beebe, Barbara R. Neas, Jodi B Segal and Zayd L. Al‐Nouri and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Deirdra R. Terrell

94 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Society of Hematology 2019 guidelines for immune thrombocytopenia

2019 730 citations Cindy Neunert, Deirdra R. Terrell et al. Blood Advances profile →

Peers

Deirdra R. Terrell

HEMAT

IMMUN

NEPHR

GENET

PFM

Alexandre Karras France

Ri Liesner United Kingdom

Nancy M. Dunbar United States

Anand Padmanabhan United States

Volker Witt Austria

Mark Weinstein United States

Laura Connelly‐Smith United States

Hubert Nivet France

Nesrin Beşbaş Türkiye

Bruno Ranchin France

Alexandre Karras France

Deirdra R. Terrell

866 ×0.3

HEMAT

1.3k ×0.5

IMMUN

2.0k ×1.1

NEPHR

673 ×0.6

GENET

492 ×1.0

PFM

Citations per year, relative to Deirdra R. Terrell Deirdra R. Terrell (= 1×) peers Alexandre Karras

Countries citing papers authored by Deirdra R. Terrell

Since Specialization

Citations

This map shows the geographic impact of Deirdra R. Terrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deirdra R. Terrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deirdra R. Terrell more than expected).

Fields of papers citing papers by Deirdra R. Terrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deirdra R. Terrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deirdra R. Terrell. The network helps show where Deirdra R. Terrell may publish in the future.

Co-authorship network of co-authors of Deirdra R. Terrell

This figure shows the co-authorship network connecting the top 25 collaborators of Deirdra R. Terrell. A scholar is included among the top collaborators of Deirdra R. Terrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deirdra R. Terrell. Deirdra R. Terrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beebe, Laura A., et al.. (2024). Implementation of Primary Immune Thrombocytopenia Clinical Practice Guidelines for Management of Pregnancy. Journal of Clinical Medicine. 13(21). 6477–6477. 2 indexed citations

Warsame, Rahma, Melody Smith, Arturo Molina, et al.. (2024). American Society of Hematology: building a comprehensive minority recruitment and retention professional program. Blood Advances. 8(24). 6237–6247. 1 indexed citations

Neunert, Cindy, Donald M. Arnold, Rachael F. Grace, et al.. (2024). The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia. Blood Advances. 8(13). 3578–3582. 13 indexed citations

Kaplan, Samantha, et al.. (2023). Patient-Reported Outcome Measures in Patients with Thrombotic Thrombocytopenic Purpura: A Systematic Review of the Literature. Journal of Clinical Medicine. 12(15). 5155–5155. 2 indexed citations

Terrell, Deirdra R., et al.. (2023). Burden of immune thrombocytopenia (ITP): Special considerations for refractory ITP. British Journal of Haematology. 203(1). 79–85. 1 indexed citations

Mattison, Ryan J., Rachel S. Bercovitz, Richard Lottenberg, et al.. (2023). Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee. Blood Advances. 7(16). 4323–4326. 1 indexed citations

Hovinga, Johanna A. Kremer, et al.. (2023). Cattle-FRETS71, a novel fluorogenic substrate with broad applicability for characterizing ADAMTS13 properties and function. Journal of Thrombosis and Haemostasis. 21(12). 3393–3401. 2 indexed citations

Neunert, Cindy, Deirdra R. Terrell, Donald M. Arnold, et al.. (2019). American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Advances. 3(23). 3829–3866. 730 indexed citations breakdown →

Terrell, Deirdra R., Spero R. Cataland, Laura A. Beebe, et al.. (2019). Impact of Residual Effects and Complications of Thrombotic Thrombocytopenic Purpura (TTP) on Daily Living: A Qualitative Study. Blood. 134(Supplement_1). 931–931. 3 indexed citations

10.

Pishko, Allyson M., Mudi Misgav, Adam Cuker, et al.. (2018). Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist–oncologists. Journal of Thrombosis and Thrombolysis. 46(1). 24–30. 15 indexed citations

11.

Rodeghiero, Francesco, David R. Anderson, Beng H. Chong, et al.. (2016). Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia. Annals of Hematology. 95(7). 1077–1087. 42 indexed citations

12.

George, James N., et al.. (2013). Management of Primary Immune Thrombocytopenia, 2012: A Survey of Oklahoma Hematologists-Oncologists. The American Journal of the Medical Sciences. 347(3). 190–194. 15 indexed citations

13.

George, JN, Sara K. Vesely, Deirdra R. Terrell, et al.. (2011). Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica. 97(2). 297–303. 55 indexed citations

14.

Swisher, Karen K., Deirdra R. Terrell, Sara K. Vesely, et al.. (2009). Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion. 49(5). 873–887. 80 indexed citations

15.

George, James N., Johanna A. Kremer Hovinga, Deirdra R. Terrell, Sara K. Vesely, & Bernhard Lämmle. (2008). The Oklahoma Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome Registry: the Swiss connection. European Journal Of Haematology. 80(4). 277–286. 34 indexed citations

16.

Mathias, Susan D., et al.. (2008). Long‐term deficits in health‐related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion. 49(1). 118–124. 60 indexed citations

17.

Li, Xiaoning, Deirdra R. Terrell, Johanna A. Kremer Hovinga, et al.. (2008). Sporadic bloody diarrhoea‐associated thrombotic thrombocytopenic purpura‐haemolytic uraemic syndrome: an adult and paediatric comparison. British Journal of Haematology. 141(5). 696–707. 43 indexed citations

18.

Terrell, Deirdra R., Lauren A. Williams, Sara K. Vesely, et al.. (2005). The incidence of thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS‐13 deficiency. Journal of Thrombosis and Haemostasis. 3(7). 1432–1436. 231 indexed citations

19.

Vesely, Sara K., Jedidiah J. Perdue, Mujahid A. Rizvi, Deirdra R. Terrell, & James N. George. (2004). Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy. Annals of Internal Medicine. 16 indexed citations

20.

George, James N., Sara K. Vesely, & Deirdra R. Terrell. (2004). The Oklahoma thrombotic thrombocytopenic Purpura-Hemolytic uremic syndrome (TTP-HUS) registry: a community perspective of patients with clinically diagnosed TTP-HUS. Seminars in Hematology. 41(1). 60–67. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact